Alivus Life Sciences Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -

1,051.55 +29.60 (2.90%)Updated : 12 Jun 2026

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	-8.02	-4.49	-2.21	-1.13
Net Changein Cash	-69.08	-230.35	17.59	-228.33
Cash Taxes Paid	173.26	162.95	162.96	153.57
Net Income/ Starting Line	751.31	654.13	631.29	628.61
Total Cash Dividends Paid	-61.34	-	-275.69	-385.92
Changesin Working Capital	-301.80	-343.33	-297.04	-367.23
Cashfrom Operating Activities	565.41	391.52	413.52	306.01
Cash Interest Paid	5.37	2.41	1.55	0.55
Cashfrom Financing Activities	-64.34	-6.23	-279.44	-387.59
Issuance( Retirement)of Stock Net	10.39	0.67	-	-
Depreciation/ Depletion	75.36	60.61	53.45	42.09
Other Investing Cash Flow Items Total	-263.10	-449.46	12.49	16.05
Capital Expenditures	-307.06	-166.19	-128.97	-162.80
period Type	-	-	-	-
Non- Cash Items	40.55	20.11	25.82	2.53
Financing Cash Flow Items	-5.37	-2.41	-1.55	-0.55
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-570.15	-615.65	-116.48	-146.75

*All figures in crores except per share values

Trending Stocks

919.20+48.90(5.62%)

4,047.15+187.70(4.86%)

391.65+15.85(4.22%)

1,432.00-32.75 (-2.24%)

285.00-1.65 (-0.58%)

Related News